Denemek ALTIN - Özgür
Ombudsman rules, but are health insurers playing fair?
Mint Ahmedabad
|October 09, 2025
How to enforce ombudsman awards, challenge cancellations, ensure uninterrupted coverage
When 60-year-old Lakhwinder S. Lamba finally got his health insurer to pay for his heart surgery after a yearlong battle, he thought the worst was over.
Then came another shock—his insurer refused to renew his policy altogether.
“[ had undergone a precautionary heart scan in 2006. Nothing significant came up in the report and no treatment ever happened. I happened to mention it to the treating doctor when I got hos-pitalised in May 2023 for an open heart surgery. The insurer rejected my claim [for the surgery] and cancelled the policy saying that I hid a preexisting disease. But I had no heart ailment when I bought the policy in 2015,” said Lamba, who retired from an IT hardware and software sales business in New Delhi.
Lambv’s insurer reimbursed him for the surgery after the insurance ombudsman ruled in his favour, but cancelled his policy. “I had received my claim in April 2024. I've been chasing them to renew my policy since then, but no luck so far,” he said.
Health insurers cannot deny a claim on grounds of nondisclosure of preexisting diseases if a policy has run continuously for at least five years, except in cases of fraud or deliberate misrepresentation. But Lamba, who says he didn’t have any heart-related ailments when he took the policy in 2015, isn’t alone in such run-ins with health insurers. "We have been receiving a lot of such cases where despite claims (being approved) by the ombudsman, can-celled policies don’t get reinstated,” said Shilpa Arora, co-founder and chief operating officer of Insurance Sama-dhan, an insurance grievance redressal platform.
Meerut-based Azhar Ahmed, 33, had a similar experience. He bought a health insurance policy for his family in 2022 and was hospitalised in 2024 for kidney stones.
Bu hikaye Mint Ahmedabad dergisinin October 09, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Ahmedabad'den DAHA FAZLA HİKAYE
Mint Ahmedabad
Trio win Nobel chemistry prize for metal-organic frameworks
Scientists Susumu Kitagawa, Richard Robson and Omar Yaghi won the 2025 Nobel chemistry prize for developing a new form of molecular architecture, yielding materials that can help tackle challenges such as climate change and lack of fresh water.
1 min
October 09, 2025
Mint Ahmedabad
India pulls dumping levies on China, others
“India appears to be balancing its industrial and strategic priorities,” said Ajay Srivastava, founder of the Global Trade Research Initiative (GTR), a trade thinktank.
1 mins
October 09, 2025
Mint Ahmedabad
Fraudsters will mourn the end of UPI payment requests
The National Payments Corporation of India (NPCI) has phased out a major feature of the Unified Payments Interface (UPI) that has long made peer-to-peer (P2P) transactions both convenient and risky. From 1 October, the \"collect request\" option for P2P transactions has been withdrawn. This is a decisive step to combat a surge in financial fraud within India's digital payments ecosystem.
3 mins
October 09, 2025

Mint Ahmedabad
Sebi preps plan for quantum threat
The Securities and Exchange Board of India (Sebi) is bracing India’s markets for a future where ultra-powerful quantum computers could crack today’s passwords in seconds—a threat its chief likened to the Y2K scare of the 1990s.
1 min
October 09, 2025

Mint Ahmedabad
Advertisers push for transparency standards in ad sales
Some of the advertising industry's largest players have joined forces to propose new standards for transparency in the digital auctions that increasingly dominate ad sales.
1 mins
October 09, 2025

Mint Ahmedabad
Trump wants to overhaul drug sales. A company tied to his son stands to benefit.
The country’s top drugmakers are set to meet in early December at the Four Seasons hotel in Georgetown with Donald Trump Jr. and senior Trump administration officials that regulate the pharmaceutical industry.
4 mins
October 09, 2025
Mint Ahmedabad
SBI eyes deal finance on home turf as Indian banks may get an entry
Having financed India Inc.’s overseas buyouts for long, State Bank of India (SBI) sees itself ready to underwrite mergers and acquisitions (M&As) at home, as the Reserve Bank of India (RBI) considers opening that door for domestic lenders.
2 mins
October 09, 2025

Mint Ahmedabad
America should think before it slams its door on immigration
The benefits of it are subtle but compelling enough to keep it going
3 mins
October 09, 2025
Mint Ahmedabad
Lord's Mark secures US FDA registration, boosting Indian healthcare manufacturing
Lord's Mark Industries Limited has received US FDA registration for its range of surgical consumables, orthopaedic supports, and hygiene products, marking a major milestone in its global expansion and reinforcing India's position in the international healthcare supply chain.
2 mins
October 09, 2025
Mint Ahmedabad
America's soybean farmers are panicking over the loss of Chinese buyers
China hasn't booked any U.S. soybean purchases in months; farmers warn of 'bloodbath'
4 mins
October 09, 2025
Listen
Translate
Change font size